首页 > 最新文献

International Journal of Laboratory Hematology最新文献

英文 中文
Influence of In Vitro Acidification on APTT Measured With Two Different Reagents on Two Different Analyzers 体外酸化对两种试剂在两种不同分析仪上测定APTT的影响。
IF 2.2 4区 医学 Q3 HEMATOLOGY Pub Date : 2025-05-09 DOI: 10.1111/ijlh.14491
Debora Olioso, Elia Ponchini, Simone Denitto, Nicola Baratto, Alessandro Lorenzetto, Davide Demonte, Giuseppe Lippi
{"title":"Influence of In Vitro Acidification on APTT Measured With Two Different Reagents on Two Different Analyzers","authors":"Debora Olioso, Elia Ponchini, Simone Denitto, Nicola Baratto, Alessandro Lorenzetto, Davide Demonte, Giuseppe Lippi","doi":"10.1111/ijlh.14491","DOIUrl":"10.1111/ijlh.14491","url":null,"abstract":"","PeriodicalId":14120,"journal":{"name":"International Journal of Laboratory Hematology","volume":"47 4","pages":"767-769"},"PeriodicalIF":2.2,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144059027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paediatric Reference Intervals and Curves for Haemoglobin Estimated Using Direct Methods: A Systematic Review and Meta-Analysis 使用直接方法估算儿科血红蛋白参考区间和曲线:一项系统回顾和荟萃分析。
IF 2.2 4区 医学 Q3 HEMATOLOGY Pub Date : 2025-05-03 DOI: 10.1111/ijlh.14489
Vid Bijelić, Marijana Bijelić, Josh Larock, Michael Pham, Franco Momoli, Mira Liebman, Beth K. Potter, Patricia C. Parkin, Jemila S. Hamid

Introduction

Haemoglobin is a commonly ordered laboratory test, used to assess both individual and population-level health. To interpret test results, laboratories provide reference intervals (RIs) with lower (2.5th%) and upper (97.5th%) limits according to age and sex. Reference curves (RCs) treat age as a continuous variable. The objectives were to synthesise evidence on Paediatric haemoglobin RIs/RCs and investigate possible sources of heterogeneity. We placed our findings in the context of the age- and sex-based haemoglobin thresholds to define anaemia, recommended for international use by WHO.

Methods

We conducted a systematic review of studies publishing Paediatric haemoglobin RIs/RCs (PROSPERO: CRD42023399802). EMBASE, MEDLINE, SCOPUS and The Cochrane electronic libraries were searched from inception to July 31, 2023. Studies involving unhealthy children, lacking males and females RIs/RCs, or limited to cord-blood RIs/RCs were excluded. Studies adhering to guidelines for RIs development from the Clinical Laboratory Standards Institute (CLSI) and RCs studies reporting confidence intervals (CIs) were included in the meta-analysis. Lower and upper males and females RI limits were pooled for age groups with heterogeneity I2 < 75%. All studies meeting eligibility criteria were included in the narrative synthesis. Sources of heterogeneity were analyzed using heatmaps, forest plots and Shiny app.

Results

Of 9123 studies screened, 177 were retained for full-text review. We identified 48 eligible studies (63 529 male and 59 969 female participants) from 25 countries (4 continents) published 1938–2023. There was inconsistency in age partitioning and length of age intervals. Meta-analysis was conducted on 13 studies reporting RIs and 2 studies reporting RCs. Pooled estimates for the 0–3 months age group could not be generated for males or females due to paucity of data. For children aged 3 months or older, both lower and upper RI limits generally increased with age, from approximately 100 to 130 g/L and from approximately 130 to 150 g/L, respectively. For visualisation of our narrative synthesis of all 48 studies, we created a novel web-based computational tool using Shiny-app. Sources of heterogeneity included child age, sex, analyser type and country. For many studies, the lower RIs were substantially different from WHO anaemia thresholds. Study limitations include a small sample size for younger age groups, potentially impacting heterogeneity estimates, reliance on CLSI guidelines due to the lack of a suitable quality assessm

血红蛋白是一种常用的实验室检测,用于评估个人和群体水平的健康状况。为了解释检测结果,实验室根据年龄和性别提供了下限(2.5%)和上限(97.5%)的参考区间(RIs)。参考曲线(rc)将年龄视为一个连续变量。目的是综合儿科血红蛋白RIs/RCs的证据,并调查异质性的可能来源。我们将研究结果置于世卫组织推荐的用于定义贫血的基于年龄和性别的血红蛋白阈值的背景下。方法:我们对发表儿科血红蛋白RIs/RCs的研究进行了系统回顾(PROSPERO: CRD42023399802)。检索了EMBASE、MEDLINE、SCOPUS和Cochrane电子图书馆,检索时间从建库到2023年7月31日。排除了涉及不健康儿童、缺乏男性和女性RIs/RCs或仅限于脐带血RIs/RCs的研究。遵循临床实验室标准协会(CLSI) RIs开发指南的研究和报告置信区间(ci)的rc研究被纳入meta分析。研究汇总了具有异质性的年龄组男性和女性RI上限的高低。结果:在筛选的9123项研究中,有177项被保留用于全文综述。我们从25个国家(4大洲)1938-2023年发表的48项符合条件的研究(63529名男性和59969名女性参与者)中筛选出。年龄划分和年龄间隔长度不一致。对13项报告RIs的研究和2项报告rc的研究进行meta分析。由于缺乏数据,无法对0-3个月年龄组的男性或女性进行汇总估计。对于3个月或更大的儿童,RI下限和上限通常随年龄增长而增加,分别从大约100到130 g/L和从大约130到150 g/L。为了可视化我们对所有48项研究的叙述综合,我们使用shine -app创建了一个新颖的基于网络的计算工具。异质性的来源包括儿童年龄、性别、分析者类型和国家。在许多研究中,较低的RIs与WHO的贫血阈值有很大不同。研究的局限性包括年轻年龄组的样本量小,可能影响异质性估计,由于缺乏合适的RIs/ rc质量评估工具而依赖于CLSI指南,以及对英语研究的限制。结论:当地开发的儿科血红蛋白RIs/RCs的证据综合显示了实质性的异质性,表明需要更严格的开发估计,可以与世卫组织的阈值一起在全球范围内使用来定义贫血。未来需要对最小儿童的RIs进行研究。应探索百分位曲线以提供连续的血红蛋白图表。
{"title":"Paediatric Reference Intervals and Curves for Haemoglobin Estimated Using Direct Methods: A Systematic Review and Meta-Analysis","authors":"Vid Bijelić,&nbsp;Marijana Bijelić,&nbsp;Josh Larock,&nbsp;Michael Pham,&nbsp;Franco Momoli,&nbsp;Mira Liebman,&nbsp;Beth K. Potter,&nbsp;Patricia C. Parkin,&nbsp;Jemila S. Hamid","doi":"10.1111/ijlh.14489","DOIUrl":"10.1111/ijlh.14489","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Haemoglobin is a commonly ordered laboratory test, used to assess both individual and population-level health. To interpret test results, laboratories provide reference intervals (RIs) with lower (2.5th%) and upper (97.5th%) limits according to age and sex. Reference curves (RCs) treat age as a continuous variable. The objectives were to synthesise evidence on Paediatric haemoglobin RIs/RCs and investigate possible sources of heterogeneity. We placed our findings in the context of the age- and sex-based haemoglobin thresholds to define anaemia, recommended for international use by WHO.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a systematic review of studies publishing Paediatric haemoglobin RIs/RCs (PROSPERO: CRD42023399802). EMBASE, MEDLINE, SCOPUS and The Cochrane electronic libraries were searched from inception to July 31, 2023. Studies involving unhealthy children, lacking males and females RIs/RCs, or limited to cord-blood RIs/RCs were excluded. Studies adhering to guidelines for RIs development from the Clinical Laboratory Standards Institute (CLSI) and RCs studies reporting confidence intervals (CIs) were included in the meta-analysis. Lower and upper males and females RI limits were pooled for age groups with heterogeneity <i>I</i><sup>2</sup> &lt; 75%. All studies meeting eligibility criteria were included in the narrative synthesis. Sources of heterogeneity were analyzed using heatmaps, forest plots and Shiny app.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of 9123 studies screened, 177 were retained for full-text review. We identified 48 eligible studies (63 529 male and 59 969 female participants) from 25 countries (4 continents) published 1938–2023. There was inconsistency in age partitioning and length of age intervals. Meta-analysis was conducted on 13 studies reporting RIs and 2 studies reporting RCs. Pooled estimates for the 0–3 months age group could not be generated for males or females due to paucity of data. For children aged 3 months or older, both lower and upper RI limits generally increased with age, from approximately 100 to 130 g/L and from approximately 130 to 150 g/L, respectively. For visualisation of our narrative synthesis of all 48 studies, we created a novel web-based computational tool using Shiny-app. Sources of heterogeneity included child age, sex, analyser type and country. For many studies, the lower RIs were substantially different from WHO anaemia thresholds. Study limitations include a small sample size for younger age groups, potentially impacting heterogeneity estimates, reliance on CLSI guidelines due to the lack of a suitable quality assessm","PeriodicalId":14120,"journal":{"name":"International Journal of Laboratory Hematology","volume":"47 4","pages":"588-599"},"PeriodicalIF":2.2,"publicationDate":"2025-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ijlh.14489","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144001700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Report: Tranexamic Acid Therapy Corrects the Impaired Epinephrine Aggregation Responses of Quebec Platelet Disorder 病例报告:氨甲环酸治疗可纠正魁北克血小板紊乱的肾上腺素聚集反应受损。
IF 2.2 4区 医学 Q3 HEMATOLOGY Pub Date : 2025-04-29 DOI: 10.1111/ijlh.14492
Natalie Mathews, Subia Tasneem, Georges E. Rivard, Catherine P. M. Hayward
{"title":"Case Report: Tranexamic Acid Therapy Corrects the Impaired Epinephrine Aggregation Responses of Quebec Platelet Disorder","authors":"Natalie Mathews,&nbsp;Subia Tasneem,&nbsp;Georges E. Rivard,&nbsp;Catherine P. M. Hayward","doi":"10.1111/ijlh.14492","DOIUrl":"10.1111/ijlh.14492","url":null,"abstract":"","PeriodicalId":14120,"journal":{"name":"International Journal of Laboratory Hematology","volume":"47 4","pages":"770-772"},"PeriodicalIF":2.2,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144047403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of Lymphoma Aggressiveness Using Machine Learning Algorithms 使用机器学习算法预测淋巴瘤侵袭性。
IF 2.3 4区 医学 Q3 HEMATOLOGY Pub Date : 2025-04-23 DOI: 10.1111/ijlh.14474
Julien Cabo, Benoît Bihin, Nicolas Debortoli, Virginie Lepage, Reza Soleimani, Rhita Bennis, Julien Favresse, Thierry Vander Borght, Carlos Graux, Caroline Fervaille, Jonathan Degosserie, Marie Pouplard, François Mullier

Introduction

Lymph nodes are essential to diagnose lymphoid neoplasms, metastases, and infections. Some lymphomas, particularly aggressive non-Hodgkin lymphomas (NHL), need urgent diagnosis. Combining lymph node cytology (LNC) and flow cytometry (FC) with other rapidly available parameters through multivariable predictive models could offer valuable diagnostic information while waiting for anatomopathological results.

Materials and Methods

Results of 196 lymph node specimens were retrospectively analyzed for parameters like age, sex, LNC, FC, positron emission tomography scan, lymphocytosis, leukocytosis, lactate dehydrogenase (LDH) levels, and hemoglobin. We constructed five multivariable models predicting the aggressive nature of lymphoma as defined by the anatomopathological diagnostic. The first three were logistic regression models based on two (model 1), four (model 2), and up to 16 independent variables (model 3). The last two models were based on ensemble learning algorithms, bagging (model 4) and boosting (model 5), respectively. The performance of these five models was compared after 10-fold cross-validation, evaluating metrics such as sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC).

Results

Compared to individual variables associated with the aggressive nature of the lymphoma (AUCs from 0.69 to 0.87), the multivariable models achieved better AUCs, ranging from 0.88 to 0.94. The best model (model 5) achieved a sensitivity and a specificity of 77% and 94%, respectively.

Conclusion

LNC, FC, and other rapidly available parameters are associated with the aggressive nature of the lymphomas. It is possible to combine them in multivariable models to obtain a valuable diagnostic information and to initiate a prompt treatment.

简介:淋巴结是诊断淋巴样肿瘤、转移和感染所必需的。一些淋巴瘤,特别是侵袭性非霍奇金淋巴瘤(NHL),需要紧急诊断。通过多变量预测模型,将淋巴结细胞学(LNC)和流式细胞术(FC)与其他快速获得的参数相结合,可以在等待解剖病理结果的同时提供有价值的诊断信息。材料与方法:回顾性分析196例淋巴结标本的年龄、性别、LNC、FC、正电子发射断层扫描、淋巴细胞增多、白细胞增多、乳酸脱氢酶(LDH)水平、血红蛋白等参数。我们构建了5个多变量模型来预测淋巴瘤的侵袭性,这些模型是由解剖病理诊断来定义的。前三个是基于两个(模型1)、四个(模型2)和多达16个自变量(模型3)的逻辑回归模型。最后两个模型分别基于集成学习算法bagging(模型4)和boosting(模型5)。经过10次交叉验证后,比较了这5种模型的性能,评估了灵敏度、特异性和受试者工作特征曲线下面积(AUC)等指标。结果:与与淋巴瘤侵袭性相关的个体变量(auc从0.69到0.87)相比,多变量模型获得了更好的auc,范围从0.88到0.94。最佳模型(模型5)的敏感性和特异性分别为77%和94%。结论:LNC、FC和其他可快速获得的参数与淋巴瘤的侵袭性有关。将它们结合在多变量模型中可以获得有价值的诊断信息并及时开始治疗。
{"title":"Prediction of Lymphoma Aggressiveness Using Machine Learning Algorithms","authors":"Julien Cabo,&nbsp;Benoît Bihin,&nbsp;Nicolas Debortoli,&nbsp;Virginie Lepage,&nbsp;Reza Soleimani,&nbsp;Rhita Bennis,&nbsp;Julien Favresse,&nbsp;Thierry Vander Borght,&nbsp;Carlos Graux,&nbsp;Caroline Fervaille,&nbsp;Jonathan Degosserie,&nbsp;Marie Pouplard,&nbsp;François Mullier","doi":"10.1111/ijlh.14474","DOIUrl":"10.1111/ijlh.14474","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Lymph nodes are essential to diagnose lymphoid neoplasms, metastases, and infections. Some lymphomas, particularly aggressive non-Hodgkin lymphomas (NHL), need urgent diagnosis. Combining lymph node cytology (LNC) and flow cytometry (FC) with other rapidly available parameters through multivariable predictive models could offer valuable diagnostic information while waiting for anatomopathological results.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Materials and Methods</h3>\u0000 \u0000 <p>Results of 196 lymph node specimens were retrospectively analyzed for parameters like age, sex, LNC, FC, positron emission tomography scan, lymphocytosis, leukocytosis, lactate dehydrogenase (LDH) levels, and hemoglobin. We constructed five multivariable models predicting the aggressive nature of lymphoma as defined by the anatomopathological diagnostic. The first three were logistic regression models based on two (model 1), four (model 2), and up to 16 independent variables (model 3). The last two models were based on ensemble learning algorithms, bagging (model 4) and boosting (model 5), respectively. The performance of these five models was compared after 10-fold cross-validation, evaluating metrics such as sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Compared to individual variables associated with the aggressive nature of the lymphoma (AUCs from 0.69 to 0.87), the multivariable models achieved better AUCs, ranging from 0.88 to 0.94. The best model (model 5) achieved a sensitivity and a specificity of 77% and 94%, respectively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>LNC, FC, and other rapidly available parameters are associated with the aggressive nature of the lymphomas. It is possible to combine them in multivariable models to obtain a valuable diagnostic information and to initiate a prompt treatment.</p>\u0000 </section>\u0000 </div>","PeriodicalId":14120,"journal":{"name":"International Journal of Laboratory Hematology","volume":"47 5","pages":"859-868"},"PeriodicalIF":2.3,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144061659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variability of Argatroban Effects on the Multiple APTT Reagents in High and Low Coagulation Activity Samples 高凝血活性和低凝血活性样品中阿加曲班对多种APTT试剂影响的变异性。
IF 2.3 4区 医学 Q3 HEMATOLOGY Pub Date : 2025-04-23 DOI: 10.1111/ijlh.14488
Osamu Kumano, Masahiro Ieko, Teruto Hashiguchi, Takashi Ito, Satoshi Yamazaki, Sumiyoshi Naito, Masako Yamazaki

Introduction

Argatroban is routinely monitored using activated partial thromboplastin time (APTT), with a recommended target range of 1.5–3.0 times. Although this range was established based on clinical trial data, including several APTT reagents, the differences in reactivity among APTT reagents remain unclear. This study compared the reactivity of six commercial APTT reagents to argatroban in normal and abnormal plasma samples.

Materials and Methods

Normal samples were spiked with argatroban and five abnormal samples: low coagulation factor activity, high factor VIII, high factor VIIa, low fibrinogen, and high fibrinogen. Drug concentrations were adjusted to 0, 0.5, 1.0, 1.5, and 2.0 μg/mL in each plasma. Six APTT reagents, including silica or ellagic acid activator and phospholipids derived from synthetic or natural sources, were tested.

Results

The APTT ratio range among the six reagents was 2.4–3.2 in normal plasma at a concentration of 2.0 μg/mL. The sample showing the most expanded range was low coagulation activity (3.3–5.2), and the range in the sample with high factor VIII activity decreased (1.5–2.2).

Conclusions

A reactivity difference was observed in argatroban-spiked samples, which increased in abnormal plasma samples. APTT may not reflect the anticoagulant activity of argatroban in patients with abnormal coagulation activity. The reactivity of APTT should be confirmed in each laboratory, and patient background coagulation status should be assessed before monitoring is conducted using the APTT ratio.

简介:阿加曲班常规监测使用活化部分凝血活酶时间(APTT),推荐的目标范围为1.5-3.0倍。虽然这个范围是根据临床试验数据建立的,包括几种APTT试剂,但APTT试剂之间的反应性差异尚不清楚。本研究比较了六种商用APTT试剂在正常和异常血浆样品中对阿加曲班的反应性。材料与方法:正常样品加加阿加曲班,正常样品加加低凝血因子活性、高凝血因子VIII、高凝血因子VIIa、低纤维蛋白原、高纤维蛋白原5种异常样品加标。各组血浆药物浓度分别调整为0、0.5、1.0、1.5、2.0 μg/mL。测试了六种APTT试剂,包括二氧化硅或鞣花酸活化剂和合成或天然来源的磷脂。结果:在浓度为2.0 μg/mL的正常血浆中,6种试剂的APTT比值范围为2.4 ~ 3.2。凝血活性低的样品范围扩大最大(3.3-5.2),凝血活性高的样品范围缩小(1.5-2.2)。结论:在加了阿加曲班的样品中观察到反应性差异,在异常血浆样品中反应性增加。APTT可能不能反映凝血活性异常患者阿加曲班的抗凝活性。应在各实验室确认APTT的反应性,并在使用APTT比值进行监测前评估患者的背景凝血状态。
{"title":"Variability of Argatroban Effects on the Multiple APTT Reagents in High and Low Coagulation Activity Samples","authors":"Osamu Kumano,&nbsp;Masahiro Ieko,&nbsp;Teruto Hashiguchi,&nbsp;Takashi Ito,&nbsp;Satoshi Yamazaki,&nbsp;Sumiyoshi Naito,&nbsp;Masako Yamazaki","doi":"10.1111/ijlh.14488","DOIUrl":"10.1111/ijlh.14488","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Argatroban is routinely monitored using activated partial thromboplastin time (APTT), with a recommended target range of 1.5–3.0 times. Although this range was established based on clinical trial data, including several APTT reagents, the differences in reactivity among APTT reagents remain unclear. This study compared the reactivity of six commercial APTT reagents to argatroban in normal and abnormal plasma samples.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Materials and Methods</h3>\u0000 \u0000 <p>Normal samples were spiked with argatroban and five abnormal samples: low coagulation factor activity, high factor VIII, high factor VIIa, low fibrinogen, and high fibrinogen. Drug concentrations were adjusted to 0, 0.5, 1.0, 1.5, and 2.0 μg/mL in each plasma. Six APTT reagents, including silica or ellagic acid activator and phospholipids derived from synthetic or natural sources, were tested.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The APTT ratio range among the six reagents was 2.4–3.2 in normal plasma at a concentration of 2.0 μg/mL. The sample showing the most expanded range was low coagulation activity (3.3–5.2), and the range in the sample with high factor VIII activity decreased (1.5–2.2).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>A reactivity difference was observed in argatroban-spiked samples, which increased in abnormal plasma samples. APTT may not reflect the anticoagulant activity of argatroban in patients with abnormal coagulation activity. The reactivity of APTT should be confirmed in each laboratory, and patient background coagulation status should be assessed before monitoring is conducted using the APTT ratio.</p>\u0000 </section>\u0000 </div>","PeriodicalId":14120,"journal":{"name":"International Journal of Laboratory Hematology","volume":"47 5","pages":"923-930"},"PeriodicalIF":2.3,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ijlh.14488","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144060667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Clauss Fibrinogen Assay Clot Waveform Analysis for the Detection of Dysfibrinogenemia on Sysmex CN-6000 Sysmex CN-6000上克劳斯纤维蛋白原测定血块波形分析检测异常纤维蛋白原血症的评价。
IF 2.3 4区 医学 Q3 HEMATOLOGY Pub Date : 2025-04-22 DOI: 10.1111/ijlh.14484
Kevin Horner, Steve Kitchen

Introduction

Dysfibrinogenemia is associated with thrombosis and bleeding. Identification is important as it correlates with adverse clinical outcomes. Clot waveform analysis (CWA) measures optical changes during clot formation to generate a clot waveform curve. Mathematical interpretation allows for the determination of velocity through the first derivative (Min1). Clauss Fibrinogen (CF) Min1 correlates with fibrinogen antigen (FbAg) levels. After calibration, estimated fibrinogen antigen (eAg) can be calculated. Studies have established a ratio of functional fibrinogen activity (FbAc) to eAg (FbAc/eAg) threshold of 0.7 effective for identifying dysfibrinogenemia.

Methods

Samples were analysed by CN-6000 (Sysmex) for PT-derived fibrinogen, Thrombin and Reptilase Times, CF (Dade Innovin, Thromboclotin, Baxotrobin and Dade Thrombin respectively, Siemens) and FbAg (Liaphen Fibrinogen, Hyphen), along with CF-CWA. The effectiveness of eAg for quantifying fibrinogen was compared to traditional FbAg measurements, along with the efficacy of FbAc/eAg in identifying dysfibrinogenemia relative to the classical FbAc/Ag ratio.

Results

Strong correlations between FbAg and eAg were evident in normal (R 2 0.9559) and hypofibrinogenemic (R 2 0.9119) cohorts; however, a weak correlation was observed in dysfibrinogenemic cohorts (R 2 0.3987). In the dysfibrinogenemic cohort, modification of the test dilution for calculating eAg was assessed; however, these changes did not enhance correlation. eAg values by both dilutions did not impair the ability of the FbAc/eAg ratio to distinguish dysfibrinogenemia from normal and hypofibrinogenemia cohorts, proving as effective as the FbAc/Ag ratio.

Conclusion

Our results endorse the reliability of the FbAc/eAg ratio as a cost-effective parameter for identifying dysfibrinogenemia, despite eAg quantification limitations in dysfibrinogenemia cases.

简介:异常纤维蛋白原血症与血栓和出血有关。鉴别很重要,因为它与不良临床结果相关。血块波形分析(CWA)通过测量血块形成过程中的光学变化来生成血块波形曲线。数学解释允许通过一阶导数(Min1)来确定速度。纤维蛋白原(CF) Min1与纤维蛋白原抗原(FbAg)水平相关。校准后,可以计算估计的纤维蛋白原抗原(eAg)。研究已经建立了功能性纤维蛋白原活性(FbAc)与eAg的比值(FbAc/eAg)阈值为0.7,可有效识别纤维蛋白异常血症。方法:采用CN-6000 (Sysmex)对样品进行pt衍生纤维蛋白原、凝血酶和Reptilase Times、CF (Dade Innovin、Thromboclotin、Baxotrobin和Dade Thrombin, Siemens)和FbAg (Liaphen fibrinogen, Hyphen)以及CF- cwa分析。将eAg定量纤维蛋白原的有效性与传统的FbAg测量方法进行比较,并将FbAc/eAg相对于经典的FbAc/Ag比率识别异常纤维蛋白原血症的有效性进行比较。结果:在正常(R2 0.9559)和低纤维蛋白原性(R2 0.9119)队列中,FbAg与eAg之间存在明显的强相关性;然而,在纤维蛋白异常队列中观察到弱相关性(R2 0.3987)。在纤维蛋白异常队列中,评估了用于计算eAg的试验稀释度的修改;然而,这些变化并没有增强相关性。两种稀释的eAg值都没有损害FbAc/eAg比值区分异常纤维蛋白原血症与正常和低纤维蛋白原血症的能力,证明与FbAc/Ag比值一样有效。结论:我们的研究结果支持了FbAc/eAg比值作为鉴别纤维蛋白异常原血症的成本效益参数的可靠性,尽管在纤维蛋白异常原血症病例中eAg的定量限制。
{"title":"Evaluation of Clauss Fibrinogen Assay Clot Waveform Analysis for the Detection of Dysfibrinogenemia on Sysmex CN-6000","authors":"Kevin Horner,&nbsp;Steve Kitchen","doi":"10.1111/ijlh.14484","DOIUrl":"10.1111/ijlh.14484","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Dysfibrinogenemia is associated with thrombosis and bleeding. Identification is important as it correlates with adverse clinical outcomes. Clot waveform analysis (CWA) measures optical changes during clot formation to generate a clot waveform curve. Mathematical interpretation allows for the determination of velocity through the first derivative (Min1). Clauss Fibrinogen (CF) Min1 correlates with fibrinogen antigen (FbAg) levels. After calibration, estimated fibrinogen antigen (eAg) can be calculated. Studies have established a ratio of functional fibrinogen activity (FbAc) to eAg (FbAc/eAg) threshold of 0.7 effective for identifying dysfibrinogenemia.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Samples were analysed by CN-6000 (Sysmex) for PT-derived fibrinogen, Thrombin and Reptilase Times, CF (Dade Innovin, Thromboclotin, Baxotrobin and Dade Thrombin respectively, Siemens) and FbAg (Liaphen Fibrinogen, Hyphen), along with CF-CWA. The effectiveness of eAg for quantifying fibrinogen was compared to traditional FbAg measurements, along with the efficacy of FbAc/eAg in identifying dysfibrinogenemia relative to the classical FbAc/Ag ratio.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Strong correlations between FbAg and eAg were evident in normal (<i>R</i>\u0000 <sup>2</sup> 0.9559) and hypofibrinogenemic (<i>R</i>\u0000 <sup>2</sup> 0.9119) cohorts; however, a weak correlation was observed in dysfibrinogenemic cohorts (<i>R</i>\u0000 <sup>2</sup> 0.3987). In the dysfibrinogenemic cohort, modification of the test dilution for calculating eAg was assessed; however, these changes did not enhance correlation. eAg values by both dilutions did not impair the ability of the FbAc/eAg ratio to distinguish dysfibrinogenemia from normal and hypofibrinogenemia cohorts, proving as effective as the FbAc/Ag ratio.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Our results endorse the reliability of the FbAc/eAg ratio as a cost-effective parameter for identifying dysfibrinogenemia, despite eAg quantification limitations in dysfibrinogenemia cases.</p>\u0000 </section>\u0000 </div>","PeriodicalId":14120,"journal":{"name":"International Journal of Laboratory Hematology","volume":"47 5","pages":"915-922"},"PeriodicalIF":2.3,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144000053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relapsed Acute Promyelocytic Leukemia With PML: RARA Fusion With Vacuolated Morphology Suggestive of Acute Monocytic/Monoblastic Leukemia 复发急性早幼粒细胞白血病伴PML: RARA融合伴空泡形态提示急性单核细胞/单核细胞白血病。
IF 2.3 4区 医学 Q3 HEMATOLOGY Pub Date : 2025-04-22 DOI: 10.1111/ijlh.14485
Fang Long, Ting Li, Yingdong Xu, Fang Chen
{"title":"Relapsed Acute Promyelocytic Leukemia With PML: RARA Fusion With Vacuolated Morphology Suggestive of Acute Monocytic/Monoblastic Leukemia","authors":"Fang Long,&nbsp;Ting Li,&nbsp;Yingdong Xu,&nbsp;Fang Chen","doi":"10.1111/ijlh.14485","DOIUrl":"10.1111/ijlh.14485","url":null,"abstract":"","PeriodicalId":14120,"journal":{"name":"International Journal of Laboratory Hematology","volume":"47 5","pages":"788-790"},"PeriodicalIF":2.3,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144061663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-Speed Centrifugation Fails to Mitigate Severe Lipemic Interference in D-dimer Measurement 高速离心不能减轻严重的脂质干扰在d -二聚体测量。
IF 2.3 4区 医学 Q3 HEMATOLOGY Pub Date : 2025-04-16 DOI: 10.1111/ijlh.14479
Xiaoping Xu, Shuqian Cai, Junchi Xue, Junqi Wu

Objective

To evaluate the impact of varying lipid turbidity (LT) levels on D-dimer measurements after routine centrifugation (RC) and high-speed centrifugation (HC) in lipemic samples.

Methods

Lipemic samples (triglyceride > 1.7 mmol/L) were classified into four LT grades via HIL testing and visual inspection. Coagulation parameters (APTT, TT, FIB, PT-INR, and D-dimer) were compared between RC (2600 × g/10 min) and HC (10 000 × g/10 min) in 104 lipemic and 30 non-lipemic control samples.

Results

Significant differences (p < 0.05) were observed in all coagulation indices between RC and HC for lipemic samples. LT level was positively correlated with TG and total cholesterol (TC). Deviation rates for APTT, TT, FIB, and PT-INR were below 15%, while D-dimer deviation rates exceeded 50% in severe LT (grades 3–4). D-dimer levels in the lipid layer were significantly higher than those in the plasma layer (p < 0.05). HC failed to resolve interference in severely turbid samples, where D-dimer adhered to chylomicron-rich lipid fractions.

Conclusion

Contrary to CLSI recommendations, high-speed centrifugation (HC) significantly reduced D-dimer concentrations in the lower plasma layer of severely turbid specimens (e.g., type II hyperlipidemia), failing to mitigate turbidity interference. This discrepancy may lead to misdiagnosis of high-risk thrombotic conditions, such as pancreatitis. The upper lipid layer, predominantly composed of chylomicrons, exhibits a strong binding affinity with D-dimer, further complicating accurate measurement. Direct dilution, however, may resolve measurement failures in severe LT samples by maintaining analyte integrity while eliminating lipid interference.

目的:评价脂质浊度(LT)水平对常规离心(RC)和高速离心(HC)后血脂样品d -二聚体测定的影响。方法:脂质样品(甘油三酯> 1.7 mmol/L)通过HIL检测和目测分为4个LT等级。比较了104例脂血症对照和30例非脂血症对照的RC (2600 × g/10 min)和HC (10 000 × g/10 min)的凝血参数(APTT、TT、FIB、PT-INR和d -二聚体)。结论:与CLSI建议相反,高速离心(HC)显著降低了严重浑浊标本(如II型高脂血症)下血浆层d -二聚体浓度,未能减轻浑浊干扰。这种差异可能导致高风险血栓性疾病的误诊,如胰腺炎。主要由乳糜微粒组成的上层脂质层与d -二聚体具有很强的结合亲和力,这进一步使精确测量复杂化。然而,直接稀释可以通过保持分析物的完整性同时消除脂质干扰来解决严重LT样品的测量失败。
{"title":"High-Speed Centrifugation Fails to Mitigate Severe Lipemic Interference in D-dimer Measurement","authors":"Xiaoping Xu,&nbsp;Shuqian Cai,&nbsp;Junchi Xue,&nbsp;Junqi Wu","doi":"10.1111/ijlh.14479","DOIUrl":"10.1111/ijlh.14479","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To evaluate the impact of varying lipid turbidity (LT) levels on D-dimer measurements after routine centrifugation (RC) and high-speed centrifugation (HC) in lipemic samples.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Lipemic samples (triglyceride &gt; 1.7 mmol/L) were classified into four LT grades via HIL testing and visual inspection. Coagulation parameters (APTT, TT, FIB, PT-INR, and D-dimer) were compared between RC (2600 × <i>g</i>/10 min) and HC (10 000 × <i>g</i>/10 min) in 104 lipemic and 30 non-lipemic control samples.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Significant differences (<i>p</i> &lt; 0.05) were observed in all coagulation indices between RC and HC for lipemic samples. LT level was positively correlated with TG and total cholesterol (TC). Deviation rates for APTT, TT, FIB, and PT-INR were below 15%, while D-dimer deviation rates exceeded 50% in severe LT (grades 3–4). D-dimer levels in the lipid layer were significantly higher than those in the plasma layer (<i>p</i> &lt; 0.05). HC failed to resolve interference in severely turbid samples, where D-dimer adhered to chylomicron-rich lipid fractions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Contrary to CLSI recommendations, high-speed centrifugation (HC) significantly reduced D-dimer concentrations in the lower plasma layer of severely turbid specimens (e.g., type II hyperlipidemia), failing to mitigate turbidity interference. This discrepancy may lead to misdiagnosis of high-risk thrombotic conditions, such as pancreatitis. The upper lipid layer, predominantly composed of chylomicrons, exhibits a strong binding affinity with D-dimer, further complicating accurate measurement. Direct dilution, however, may resolve measurement failures in severe LT samples by maintaining analyte integrity while eliminating lipid interference.</p>\u0000 </section>\u0000 </div>","PeriodicalId":14120,"journal":{"name":"International Journal of Laboratory Hematology","volume":"47 5","pages":"906-914"},"PeriodicalIF":2.3,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144065509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knizocytes in an Infant With Hemoglobin CE 血红蛋白CE患儿的刀状细胞。
IF 2.3 4区 医学 Q3 HEMATOLOGY Pub Date : 2025-04-10 DOI: 10.1111/ijlh.14482
Amr Elgehiny, Sara E. Amin, Ahmed H. Hussein, Nghia D. Nguyen, Lakshmi V. Srivaths
{"title":"Knizocytes in an Infant With Hemoglobin CE","authors":"Amr Elgehiny,&nbsp;Sara E. Amin,&nbsp;Ahmed H. Hussein,&nbsp;Nghia D. Nguyen,&nbsp;Lakshmi V. Srivaths","doi":"10.1111/ijlh.14482","DOIUrl":"10.1111/ijlh.14482","url":null,"abstract":"","PeriodicalId":14120,"journal":{"name":"International Journal of Laboratory Hematology","volume":"47 5","pages":"786-787"},"PeriodicalIF":2.3,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144028383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Streamlining the Diagnosis of MDS: Navigating Growing Pains Towards Greater Accuracy and Efficiency 简化MDS的诊断:导航成长的烦恼朝着更高的准确性和效率。
IF 2.2 4区 医学 Q3 HEMATOLOGY Pub Date : 2025-04-07 DOI: 10.1111/ijlh.14477
Marc Sorigue
{"title":"Streamlining the Diagnosis of MDS: Navigating Growing Pains Towards Greater Accuracy and Efficiency","authors":"Marc Sorigue","doi":"10.1111/ijlh.14477","DOIUrl":"10.1111/ijlh.14477","url":null,"abstract":"","PeriodicalId":14120,"journal":{"name":"International Journal of Laboratory Hematology","volume":"47 4","pages":"760-762"},"PeriodicalIF":2.2,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143797333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Laboratory Hematology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1